Literature DB >> 17372125

Decreased frontal choline and neuropsychological performance in preclinical Huntington disease.

B Gómez-Ansón1, M Alegret, E Muñoz, A Sainz, G C Monte, E Tolosa.   

Abstract

OBJECTIVES: To study metabolic brain changes in preclinical carriers of Huntington disease (PreHD) using proton magnetic resonance spectroscopy (1H-MRS) and to examine their relationship to neuropsychological performance.
METHODS: Seventeen subjects with PreHD and 17 controls, matched for age and education, were studied. Frontal cortex and basal ganglia 1H-MRS, and a detailed neuropsychological battery, including visuomotor integration and speed, and memory, frontal, and visuospatial tests were performed. Statistical analysis included Student t-test and Pearson correlations (significance p < 0.05).
RESULTS: Frontal choline-containing compounds (CHO) were decreased in PreHD [t (32) = -2.834, p = 0.008]. Subjects with PreHD performed worse than controls in the 15-Objects test [t (32) = 4.077, p = 0.000], Luria motor alternances [t (32) = -2.094, p = 0.044], and Symbol Digit tests [t (32) = -2.136, p = 0.040]. Decreased frontal CHO in PreHD correlated to slowing in visuomotor tasks (the 15-Objects test: r = -0.60, p = 0.000, and the Symbol Digit: r = 0.37, p = 0.047).
CONCLUSION: As choline-containing compounds relate to membrane turnover, membrane dysfunction antedating neuronal death is suggested to occur in the frontal cortex in preclinical carriers of Huntington disease. This dysfunction may be responsible for some of the neuropsychological deficits observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372125     DOI: 10.1212/01.wnl.0000257090.01107.2f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Expanded neurochemical profile in the early stage of Huntington disease using proton magnetic resonance spectroscopy.

Authors:  Isaac M Adanyeguh; Marie-Lorraine Monin; Daisy Rinaldi; Léorah Freeman; Alexandra Durr; Stéphane Lehéricy; Pierre-Gilles Henry; Fanny Mochel
Journal:  NMR Biomed       Date:  2018-01-09       Impact factor: 4.044

2.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

3.  Frontal lobe metabolic alterations characterizing Parkinson's disease cognitive impairment.

Authors:  Shefali Chaudhary; S Senthil Kumaran; Vinay Goyal; M Kalaivani; Gauri Shanker Kaloiya; Rajesh Sagar; Nalin Mehta; Achal Kumar Srivastava; N R Jagannathan
Journal:  Neurol Sci       Date:  2020-07-29       Impact factor: 3.307

4.  Neurochemical correlates of caudate atrophy in Huntington's disease.

Authors:  Jeannie M Padowski; Kurt E Weaver; Todd L Richards; Mercy Y Laurino; Ali Samii; Elizabeth H Aylward; Kevin E Conley
Journal:  Mov Disord       Date:  2014-01-17       Impact factor: 10.338

5.  Abnormal explicit but normal implicit sequence learning in premanifest and early Huntington's disease.

Authors:  Susanne A Schneider; Leonora Wilkinson; Kailash P Bhatia; Susie M D Henley; John C Rothwell; Sarah J Tabrizi; Marjan Jahanshahi
Journal:  Mov Disord       Date:  2010-07-30       Impact factor: 10.338

Review 6.  Functional imaging in Huntington's disease.

Authors:  Jane S Paulsen
Journal:  Exp Neurol       Date:  2009-01-03       Impact factor: 5.330

7.  Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Authors:  Montse Alegret; Mercè Boada-Rovira; Georgina Vinyes-Junqué; Sergi Valero; Ana Espinosa; Isabel Hernández; Gemma Modinos; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga
Journal:  J Clin Exp Neuropsychol       Date:  2009-01-14       Impact factor: 2.475

8.  Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Authors:  Andrea C Solomon; Julie C Stout; Marjorie Weaver; Sarah Queller; Allison Tomusk; Kathryn Burr Whitlock; Siu L Hui; Jeanine Marshall; Jacqueline Gray Jackson; Eric R Siemers; Xabier Beristain; Joanne Wojcieszek; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

9.  Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Authors:  Sven Schippling; Susanne A Schneider; Khailash P Bhatia; Alexander Münchau; John C Rothwell; Sarah J Tabrizi; Michael Orth
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

10.  Postoperative changes in cerebral metabolites associated with cognitive improvement and impairment after carotid endarterectomy: a 3T proton MR spectroscopy study.

Authors:  H Saito; K Ogasawara; H Nishimoto; Y Yoshioka; T Murakami; S Fujiwara; M Sasaki; M Kobayashi; K Yoshida; Y Kubo; T Beppu; A Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.